Well monitor your progress for improved metabolism, stronger immune function, and better energy
Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: a systematic review and meta-analysis
3.6 / 5.0 Rated 3.6 out of 5 By Amna Eltawil x Written By Amna Eltawil, Journalist Amna Eltawil is an Egyptian journalist who grew up on the coast of the Mediterranean in Alexandria, Egypt, before moving to Cairo and getting her bachelor's in journalism
Keeping the Weight Off Long-Term How to Maintain Your Results After Treatment Moving from active weight loss to keeping it off determines whether this works long-term
But did you know that these therapy drips might also promote detoxification
Although it is still undergoing clinical testing, early findings suggest that when comparing tirzepatide vs retatrutide, the latter may offer even greater fat loss potential than other medications, with some studies revealing an average reduction of 24.2% after 48 weeks